Home » Topics » Conferences

Conferences
RSS

In vitro characterization of novel CysLTD1 receptor antagonist

May 16, 1997

Endothelin receptor blockade for airways inflammation

May 16, 1997

Airways-selective inhaled steroid for the treatment of asthma

May 16, 1997

New hypoxic cytotoxin from Evanston Hospital

May 15, 1997

PAK-104P reverses both P-glycoprotein- and MRP-mediated MDR

May 15, 1997

Phase I/II results for Glaxo's tucaresol in metastatic melanoma

May 15, 1997

Nippon Shinyaku characterizes novel sulfonamide antitumor agent

May 15, 1997

Pharmacokinetics and tissue distribution of TOP-53

May 15, 1997

Samjin characterizes novel antitumor agent

May 14, 1997

In vitro effects of combinations of tubulin-interacting agents and S-16020-2

May 14, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 31, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 31, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...